Global Poliovirus Vaccine Inactivated Market Research Report 2024

Report ID: 1897610 | Published Date: Oct 2024 | No. of Page: 73 | Base Year: 2023 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Poliovirus Vaccine Inactivated Market Overview
    1.1 Product Overview and Scope of Poliovirus Vaccine Inactivated
    1.2 Poliovirus Vaccine Inactivated Segment by Type
        1.2.1 Global Poliovirus Vaccine Inactivated Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Human Diploid Cell
        1.2.3 Monkey Kidney Cell
    1.3 Poliovirus Vaccine Inactivated Segment by Application
        1.3.1 Global Poliovirus Vaccine Inactivated Sales Comparison by Application: (2022-2028)
        1.3.2 Public
        1.3.3 Private
    1.4 Global Poliovirus Vaccine Inactivated Market Size Estimates and Forecasts
        1.4.1 Global Poliovirus Vaccine Inactivated Revenue 2017-2028
        1.4.2 Global Poliovirus Vaccine Inactivated Sales 2017-2028
        1.4.3 Poliovirus Vaccine Inactivated Market Size by Region: 2017 Versus 2021 Versus 2028
2 Poliovirus Vaccine Inactivated Market Competition by Manufacturers
    2.1 Global Poliovirus Vaccine Inactivated Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Poliovirus Vaccine Inactivated Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Poliovirus Vaccine Inactivated Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Poliovirus Vaccine Inactivated Manufacturing Sites, Area Served, Product Type
    2.5 Poliovirus Vaccine Inactivated Market Competitive Situation and Trends
        2.5.1 Poliovirus Vaccine Inactivated Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Poliovirus Vaccine Inactivated Players Market Share by Revenue
        2.5.3 Global Poliovirus Vaccine Inactivated Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Poliovirus Vaccine Inactivated Retrospective Market Scenario by Region
    3.1 Global Poliovirus Vaccine Inactivated Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Poliovirus Vaccine Inactivated Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Poliovirus Vaccine Inactivated Market Facts & Figures by Country
        3.3.1 North America Poliovirus Vaccine Inactivated Sales by Country
        3.3.2 North America Poliovirus Vaccine Inactivated Revenue by Country
        3.3.3 the United States
        3.3.4 Canada
    3.4 Europe Poliovirus Vaccine Inactivated Market Facts & Figures by Country
        3.4.1 Europe Poliovirus Vaccine Inactivated Sales by Country
        3.4.2 Europe Poliovirus Vaccine Inactivated Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 UK
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Poliovirus Vaccine Inactivated Market Facts & Figures by Region
        3.5.1 Asia Pacific Poliovirus Vaccine Inactivated Sales by Region
        3.5.2 Asia Pacific Poliovirus Vaccine Inactivated Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Poliovirus Vaccine Inactivated Market Facts & Figures by Country
        3.6.1 Latin America Poliovirus Vaccine Inactivated Sales by Country
        3.6.2 Latin America Poliovirus Vaccine Inactivated Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Poliovirus Vaccine Inactivated Market Facts & Figures by Country
        3.7.1 Middle East and Africa Poliovirus Vaccine Inactivated Sales by Country
        3.7.2 Middle East and Africa Poliovirus Vaccine Inactivated Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Poliovirus Vaccine Inactivated Historic Market Analysis by Type
    4.1 Global Poliovirus Vaccine Inactivated Sales Market Share by Type (2017-2022)
    4.2 Global Poliovirus Vaccine Inactivated Revenue Market Share by Type (2017-2022)
    4.3 Global Poliovirus Vaccine Inactivated Price by Type (2017-2022)
5 Global Poliovirus Vaccine Inactivated Historic Market Analysis by Application
    5.1 Global Poliovirus Vaccine Inactivated Sales Market Share by Application (2017-2022)
    5.2 Global Poliovirus Vaccine Inactivated Revenue Market Share by Application (2017-2022)
    5.3 Global Poliovirus Vaccine Inactivated Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Sanofi
        6.1.1 Sanofi Corporation Information
        6.1.2 Sanofi Description and Business Overview
        6.1.3 Sanofi Poliovirus Vaccine Inactivated Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Sanofi Poliovirus Vaccine Inactivated Product Portfolio
        6.1.5 Sanofi Recent Developments/Updates
    6.2 GSK
        6.2.1 GSK Corporation Information
        6.2.2 GSK Description and Business Overview
        6.2.3 GSK Poliovirus Vaccine Inactivated Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 GSK Poliovirus Vaccine Inactivated Product Portfolio
        6.2.5 GSK Recent Developments/Updates
    6.3 Serum Institute (Bilthoven Biologicals)
        6.3.1 Serum Institute (Bilthoven Biologicals) Corporation Information
        6.3.2 Serum Institute (Bilthoven Biologicals) Description and Business Overview
        6.3.3 Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Product Portfolio
        6.3.5 Serum Institute (Bilthoven Biologicals) Recent Developments/Updates
    6.4 IMBCA
        6.4.1 IMBCA Corporation Information
        6.4.2 IMBCA Description and Business Overview
        6.4.3 IMBCA Poliovirus Vaccine Inactivated Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 IMBCA Poliovirus Vaccine Inactivated Product Portfolio
        6.4.5 IMBCA Recent Developments/Updates
7 Poliovirus Vaccine Inactivated Manufacturing Cost Analysis
    7.1 Poliovirus Vaccine Inactivated Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Poliovirus Vaccine Inactivated
    7.4 Poliovirus Vaccine Inactivated Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Poliovirus Vaccine Inactivated Distributors List
    8.3 Poliovirus Vaccine Inactivated Customers
9 Poliovirus Vaccine Inactivated Market Dynamics
    9.1 Poliovirus Vaccine Inactivated Industry Trends
    9.2 Poliovirus Vaccine Inactivated Market Drivers
    9.3 Poliovirus Vaccine Inactivated Market Challenges
    9.4 Poliovirus Vaccine Inactivated Market Restraints
10 Global Market Forecast
    10.1 Poliovirus Vaccine Inactivated Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Poliovirus Vaccine Inactivated by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Poliovirus Vaccine Inactivated by Type (2023-2028)
    10.2 Poliovirus Vaccine Inactivated Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Poliovirus Vaccine Inactivated by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Poliovirus Vaccine Inactivated by Application (2023-2028)
    10.3 Poliovirus Vaccine Inactivated Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Poliovirus Vaccine Inactivated by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Poliovirus Vaccine Inactivated by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Poliovirus Vaccine Inactivated Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Poliovirus Vaccine Inactivated Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Poliovirus Vaccine Inactivated Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Poliovirus Vaccine Inactivated Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Poliovirus Vaccine Inactivated Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Poliovirus Vaccine Inactivated Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Poliovirus Vaccine Inactivated Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Poliovirus Vaccine Inactivated Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Poliovirus Vaccine Inactivated Average Price (USD/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Poliovirus Vaccine Inactivated Manufacturing Sites and Area Served
    Table 11. Manufacturers Poliovirus Vaccine Inactivated Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Poliovirus Vaccine Inactivated by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Poliovirus Vaccine Inactivated as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Poliovirus Vaccine Inactivated Sales by Region (2017-2022) & (K Units)
    Table 16. Global Poliovirus Vaccine Inactivated Sales Market Share by Region (2017-2022)
    Table 17. Global Poliovirus Vaccine Inactivated Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Poliovirus Vaccine Inactivated Revenue Market Share by Region (2017-2022)
    Table 19. North America Poliovirus Vaccine Inactivated Sales by Country (2017-2022) & (K Units)
    Table 20. North America Poliovirus Vaccine Inactivated Sales Market Share by Country (2017-2022)
    Table 21. North America Poliovirus Vaccine Inactivated Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Poliovirus Vaccine Inactivated Revenue Market Share by Country (2017-2022)
    Table 23. Europe Poliovirus Vaccine Inactivated Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Poliovirus Vaccine Inactivated Sales Market Share by Country (2017-2022)
    Table 25. Europe Poliovirus Vaccine Inactivated Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Poliovirus Vaccine Inactivated Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Poliovirus Vaccine Inactivated Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Poliovirus Vaccine Inactivated Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Poliovirus Vaccine Inactivated Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Poliovirus Vaccine Inactivated Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Poliovirus Vaccine Inactivated Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Poliovirus Vaccine Inactivated Sales Market Share by Country (2017-2022)
    Table 33. Latin America Poliovirus Vaccine Inactivated Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Poliovirus Vaccine Inactivated Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Poliovirus Vaccine Inactivated Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Poliovirus Vaccine Inactivated Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Poliovirus Vaccine Inactivated Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Poliovirus Vaccine Inactivated Revenue Market Share by Country (2017-2022)
    Table 39. Global Poliovirus Vaccine Inactivated Sales by Type (2017-2022) & (K Units)
    Table 40. Global Poliovirus Vaccine Inactivated Sales Market Share by Type (2017-2022)
    Table 41. Global Poliovirus Vaccine Inactivated Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Poliovirus Vaccine Inactivated Revenue Share by Type (2017-2022)
    Table 43. Global Poliovirus Vaccine Inactivated Price by Type (2017-2022) & (USD/Unit)
    Table 44. Global Poliovirus Vaccine Inactivated Sales (K Units) by Application (2017-2022)
    Table 45. Global Poliovirus Vaccine Inactivated Sales Market Share by Application (2017-2022)
    Table 46. Global Poliovirus Vaccine Inactivated Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Poliovirus Vaccine Inactivated Revenue Share by Application (2017-2022)
    Table 48. Global Poliovirus Vaccine Inactivated Price by Application (2017-2022) & (USD/Unit)
    Table 49. Sanofi Corporation Information
    Table 50. Sanofi Description and Business Overview
    Table 51. Sanofi Poliovirus Vaccine Inactivated Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 52. Sanofi Poliovirus Vaccine Inactivated Product
    Table 53. Sanofi Recent Developments/Updates
    Table 54. GSK Corporation Information
    Table 55. GSK Description and Business Overview
    Table 56. GSK Poliovirus Vaccine Inactivated Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 57. GSK Poliovirus Vaccine Inactivated Product
    Table 58. GSK Recent Developments/Updates
    Table 59. Serum Institute (Bilthoven Biologicals) Corporation Information
    Table 60. Serum Institute (Bilthoven Biologicals) Description and Business Overview
    Table 61. Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 62. Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Product
    Table 63. Serum Institute (Bilthoven Biologicals) Recent Developments/Updates
    Table 64. IMBCA Corporation Information
    Table 65. IMBCA Description and Business Overview
    Table 66. IMBCA Poliovirus Vaccine Inactivated Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 67. IMBCA Poliovirus Vaccine Inactivated Product
    Table 68. IMBCA Recent Developments/Updates
    Table 69. Production Base and Market Concentration Rate of Raw Material
    Table 70. Key Suppliers of Raw Materials
    Table 71. Poliovirus Vaccine Inactivated Distributors List
    Table 72. Poliovirus Vaccine Inactivated Customers List
    Table 73. Poliovirus Vaccine Inactivated Market Trends
    Table 74. Poliovirus Vaccine Inactivated Market Drivers
    Table 75. Poliovirus Vaccine Inactivated Market Challenges
    Table 76. Poliovirus Vaccine Inactivated Market Restraints
    Table 77. Global Poliovirus Vaccine Inactivated Sales Forecast by Type (2023-2028) & (K Units)
    Table 78. Global Poliovirus Vaccine Inactivated Sales Market Share Forecast by Type (2023-2028)
    Table 79. Global Poliovirus Vaccine Inactivated Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 80. Global Poliovirus Vaccine Inactivated Revenue Market Share Forecast by Type (2023-2028)
    Table 81. Global Poliovirus Vaccine Inactivated Sales Forecast by Application (2023-2028) & (K Units)
    Table 82. Global Poliovirus Vaccine Inactivated Sales Market Share Forecast by Application (2023-2028)
    Table 83. Global Poliovirus Vaccine Inactivated Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 84. Global Poliovirus Vaccine Inactivated Revenue Market Share Forecast by Application (2023-2028)
    Table 85. Global Poliovirus Vaccine Inactivated Sales Forecast by Region (2023-2028) & (K Units)
    Table 86. Global Poliovirus Vaccine Inactivated Sales Market Share Forecast by Region (2023-2028)
    Table 87. Global Poliovirus Vaccine Inactivated Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 88. Global Poliovirus Vaccine Inactivated Revenue Market Share Forecast by Region (2023-2028)
    Table 89. Research Programs/Design for This Report
    Table 90. Key Data Information from Secondary Sources
    Table 91. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Poliovirus Vaccine Inactivated
    Figure 2. Global Poliovirus Vaccine Inactivated Market Share by Type in 2021 & 2028
    Figure 3. Human Diploid Cell Product Picture
    Figure 4. Monkey Kidney Cell Product Picture
    Figure 5. Global Poliovirus Vaccine Inactivated Market Share by Application in 2021 & 2028
    Figure 6. Public
    Figure 7. Private
    Figure 8. Global Poliovirus Vaccine Inactivated Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 9. Global Poliovirus Vaccine Inactivated Market Size (2017-2028) & (US$ Million)
    Figure 10. Global Poliovirus Vaccine Inactivated Sales (2017-2028) & (K Units)
    Figure 11. Poliovirus Vaccine Inactivated Sales Share by Manufacturers in 2021
    Figure 12. Global Poliovirus Vaccine Inactivated Revenue Share by Manufacturers in 2021
    Figure 13. The Global 5 and 10 Largest Poliovirus Vaccine Inactivated Players: Market Share by Revenue in 2021
    Figure 14. Poliovirus Vaccine Inactivated Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 15. Global Poliovirus Vaccine Inactivated Sales Market Share by Region (2017-2022)
    Figure 16. Global Poliovirus Vaccine Inactivated Sales Market Share by Region in 2021
    Figure 17. Global Poliovirus Vaccine Inactivated Revenue Market Share by Region (2017-2022)
    Figure 18. Global Poliovirus Vaccine Inactivated Revenue Market Share by Region in 2021
    Figure 19. the United States Poliovirus Vaccine Inactivated Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 20. Canada Poliovirus Vaccine Inactivated Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 21. Germany Poliovirus Vaccine Inactivated Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. France Poliovirus Vaccine Inactivated Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. UK Poliovirus Vaccine Inactivated Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Italy Poliovirus Vaccine Inactivated Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Russia Poliovirus Vaccine Inactivated Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. China Poliovirus Vaccine Inactivated Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Japan Poliovirus Vaccine Inactivated Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. South Korea Poliovirus Vaccine Inactivated Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. India Poliovirus Vaccine Inactivated Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Australia Poliovirus Vaccine Inactivated Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. China Taiwan Poliovirus Vaccine Inactivated Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Indonesia Poliovirus Vaccine Inactivated Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Thailand Poliovirus Vaccine Inactivated Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Malaysia Poliovirus Vaccine Inactivated Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Mexico Poliovirus Vaccine Inactivated Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Brazil Poliovirus Vaccine Inactivated Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Argentina Poliovirus Vaccine Inactivated Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Turkey Poliovirus Vaccine Inactivated Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Saudi Arabia Poliovirus Vaccine Inactivated Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. UAE Poliovirus Vaccine Inactivated Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Sales Market Share of Poliovirus Vaccine Inactivated by Type (2017-2022)
    Figure 42. Manufacturing Cost Structure of Poliovirus Vaccine Inactivated
    Figure 43. Manufacturing Process Analysis of Poliovirus Vaccine Inactivated
    Figure 44. Poliovirus Vaccine Inactivated Industrial Chain Analysis
    Figure 45. Channels of Distribution
    Figure 46. Distributors Profiles
    Figure 47. Bottom-up and Top-down Approaches for This Report
    Figure 48. Data Triangulation
    Figure 49. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi
GSK
Serum Institute (Bilthoven Biologicals)
IMBCA
Frequently Asked Questions
Poliovirus Vaccine Inactivated report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Poliovirus Vaccine Inactivated report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Poliovirus Vaccine Inactivated report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports